Search Results 1-10 of 28552 for intestinal metaplasia

1. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

   Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...

2. Gastrointestinal Neoplasia Clinic - Overview

   Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

3. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

   That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

4. Barrett's esophagus - Symptoms and causes - Mayo Clinic

   Frequent heartburn and regurgitation of stomach contents; Difficulty swallowing food; Less commonly, chest pain. Curiously, approximately half of the people ...

5. Stomach cancer - Symptoms and causes - Mayo Clinic

   Stomach cancer, which is also called gastric cancer, is cancer that begins in the stomach. Learn about symptoms, causes, detection and treatments.

6. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

7. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

   ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

8. Barrett's Esophagus Clinical Trials

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

9. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

10. Screening strategies for prevalent esophageal adenocarcinoma may be different from those recommended for Barrett's esophagus - Mayo Clinic

    "Our results suggest the existence of an alternative pathway — one in which metaplasia progresses rapidly to EAC , with or without intestinal metaplasia," says ...